144 related articles for article (PubMed ID: 1574528)
1. Behavioral effects of some diphenyl-substituted antimuscarinics: comparison with cocaine and atropine.
Witkin JM; Genovese RF; Witkin KM; Chiang PK
Pharmacol Biochem Behav; 1992 Feb; 41(2):377-84. PubMed ID: 1574528
[TBL] [Abstract][Full Text] [Related]
2. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
Witkin JM; Gordon RK; Chiang PK
J Pharmacol Exp Ther; 1987 Sep; 242(3):796-803. PubMed ID: 3498817
[TBL] [Abstract][Full Text] [Related]
3. Effects of some antimuscarinics alone and in combination with chlordiazepoxide on punished and nonpunished behavior of rats.
Witkin JM; Witkin KM
Pharmacol Biochem Behav; 1991 Jun; 39(2):453-6. PubMed ID: 1946585
[TBL] [Abstract][Full Text] [Related]
4. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
Vargas HM; Ringdahl B
J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of oxotremorine-induced behavioral suppression by antimuscarinic drugs.
Leander JD
Psychopharmacology (Berl); 1981; 75(1):5-8. PubMed ID: 6795660
[TBL] [Abstract][Full Text] [Related]
6. Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine.
Katz JL; Izenwasser S; Kline RH; Allen AC; Newman AH
J Pharmacol Exp Ther; 1999 Jan; 288(1):302-15. PubMed ID: 9862785
[TBL] [Abstract][Full Text] [Related]
7. Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
Beach JE; Smallridge RC; Chiang PK; Fein HG
J Pharmacol Exp Ther; 1988 Aug; 246(2):548-52. PubMed ID: 3404446
[TBL] [Abstract][Full Text] [Related]
8. 6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.
Carroll FI; Abraham P; Parham K; Griffith RC; Ahmad A; Richard MM; Padilla FN; Witkin JM; Chiang PK
J Med Chem; 1987 May; 30(5):805-9. PubMed ID: 3494849
[TBL] [Abstract][Full Text] [Related]
9. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
Witkin JM
Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
[TBL] [Abstract][Full Text] [Related]
10. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine.
Genovese RF; Elsmore TF; Witkin JM
Pharmacol Biochem Behav; 1990 Sep; 37(1):117-22. PubMed ID: 2263653
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine.
Heidbreder CA; Shippenberg TS
Synapse; 1996 Oct; 24(2):182-92. PubMed ID: 8890460
[TBL] [Abstract][Full Text] [Related]
12. Effects of muscarinic pharmacophores on the cholinergic regulation of catecholamine secretion from perfused adrenal glands.
Nakazato Y; Oleshansky MA; Chiang PK
Arch Int Pharmacodyn Ther; 1988; 293():209-18. PubMed ID: 3421778
[TBL] [Abstract][Full Text] [Related]
13. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
Amitai G; Herz JM; Bruckstein R; Luz-Chapman S
Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366
[TBL] [Abstract][Full Text] [Related]
14. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
Genovese RF
Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
Kenakin T; Boselli C
J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of aprophen, atropine and benactyzine on central and peripheral cholinoceptors and on acetylcholinesterase.
Dawson RM; Freeman SE; Paddle BM
Biochem Pharmacol; 1985 May; 34(9):1577-9. PubMed ID: 3994766
[No Abstract] [Full Text] [Related]
17. Nonmuscarinic neurotoxicity of oxotremorine.
Witkin JM; Alvarado-Garcia R; Lee MA; Witkin KM
J Pharmacol Exp Ther; 1987 Apr; 241(1):34-41. PubMed ID: 3572794
[TBL] [Abstract][Full Text] [Related]
18. Crystal, solution, and molecular modeling structural properties and muscarinic antagonist activity of azaprophen.
Carroll FI; Abraham P; Mascarella SW; Singh P; Moreland CG; Sankar SS; Kwon YW; Triggle DJ
J Med Chem; 1991 Apr; 34(4):1436-40. PubMed ID: 2016720
[TBL] [Abstract][Full Text] [Related]
19. Effects of anticholinergic drugs on DRL performance of rhesus monkeys.
McDonough JH
Pharmacol Biochem Behav; 1982 Jul; 17(1):85-90. PubMed ID: 7122671
[TBL] [Abstract][Full Text] [Related]
20. Physostigmine-insensitive behavioral excitatory effects of atropine in squirrel monkeys.
Witkin JM; Markowitz RA; Barrett JE
Pharmacol Biochem Behav; 1989 Jan; 32(1):309-15. PubMed ID: 2734342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
